• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响 T4a 下咽癌手术治疗结局的临床病理因素。

Clinicopathological factors influencing the outcomes of surgical treatment in patients with T4a hypopharyngeal cancer.

机构信息

Department of Otolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Department of Otorhinolaryngology-Head and Neck Surgery, Ilsong Memorial Institute of Head and Neck Cancer, Hallym University, College of Medicine, Seoul, Republic of Korea.

出版信息

BMC Cancer. 2017 Dec 29;17(1):904. doi: 10.1186/s12885-017-3880-6.

DOI:10.1186/s12885-017-3880-6
PMID:29284434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5747182/
Abstract

BACKGROUND

The purpose of this study was to determine prognostic factors influencing outcomes of surgical treatment in patients with T4a hypopharyngeal cancer.

METHODS

The present study enrolled 93 patients diagnosed with T4a hypopharyngeal cancer who underwent primary surgery between January 2005 and December 2015 at six medical centers in Korea. Primary tumor sites included pyriform sinus in 71 patients, posterior pharyngeal wall in 14 patients, and postcricoid region in 8 patients. Seventy-two patients received postoperative radio(chemo)therapy.

RESULTS

Five-year disease-free survival (DFS) and disease-specific survival (DSS) rates were 38% and 45%, respectively. In univariate analysis, 5-year DFS was found to have significant and positive correlations with margin involvement (p < 0.001) and extracapsular spread (p = 0.025). Multivariate analysis confirmed that margin involvement (hazard ratio (HR): 2.81; 95% confidence interval (CI): 1.49-5.30; p = 0.001) and extracapsular spread (HR: 2.08; 95% CI: 1.08-3.99; p = 0.028) were significant factors associated with 5-year DFS. In univariate analysis, cervical lymph node metastasis (p = 0.048), lymphovascular invasion (p = 0.041), extracapsular spread (p = 0.015), and esophageal invasion (p = 0.033) were significant factors associated with 5-year DSS. In multivariate analysis, extracapsular spread (HR: 2.98; 95% CI: 1.39-6.42; p = 0.005) and esophageal invasion (HR: 2.87; 95% CI: 1.38-5.98; p = 0.005) remained significant factors associated with 5-year DSS.

CONCLUSION

Margin involvement and extracapsular spread are factors influencing recurrence while extracapsular spread and esophageal invasion are factors affecting survival in patients with T4a hypopharyngeal cancer treated by primary surgery.

摘要

背景

本研究旨在确定影响 T4a 下咽癌手术治疗结果的预后因素。

方法

本研究纳入了 93 例在韩国 6 家医疗中心于 2005 年 1 月至 2015 年 12 月期间接受原发手术治疗的 T4a 下咽癌患者。原发肿瘤部位包括梨状窦 71 例,咽后壁 14 例,环后区 8 例。72 例患者接受术后放化疗。

结果

5 年无病生存率(DFS)和疾病特异性生存率(DSS)分别为 38%和 45%。单因素分析显示,5 年 DFS 与切缘累及(p<0.001)和囊外扩散(p=0.025)显著正相关。多因素分析证实,切缘累及(HR:2.81;95%CI:1.49-5.30;p=0.001)和囊外扩散(HR:2.08;95%CI:1.08-3.99;p=0.028)是与 5 年 DFS 相关的显著因素。单因素分析显示,颈部淋巴结转移(p=0.048)、淋巴血管侵犯(p=0.041)、囊外扩散(p=0.015)和食管侵犯(p=0.033)与 5 年 DSS 显著相关。多因素分析显示,囊外扩散(HR:2.98;95%CI:1.39-6.42;p=0.005)和食管侵犯(HR:2.87;95%CI:1.38-5.98;p=0.005)仍然是与 5 年 DSS 相关的显著因素。

结论

切缘累及和囊外扩散是影响复发的因素,而囊外扩散和食管侵犯是影响 T4a 下咽癌患者原发手术后生存的因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8252/5747182/11ad5783cbe3/12885_2017_3880_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8252/5747182/0180826eb6fa/12885_2017_3880_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8252/5747182/11ad5783cbe3/12885_2017_3880_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8252/5747182/0180826eb6fa/12885_2017_3880_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8252/5747182/11ad5783cbe3/12885_2017_3880_Fig2_HTML.jpg

相似文献

1
Clinicopathological factors influencing the outcomes of surgical treatment in patients with T4a hypopharyngeal cancer.影响 T4a 下咽癌手术治疗结局的临床病理因素。
BMC Cancer. 2017 Dec 29;17(1):904. doi: 10.1186/s12885-017-3880-6.
2
[Treatment and prognosis of 264 patients with hypopharyngeal carcinoma].264例下咽癌患者的治疗与预后
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 May 7;53(5):346-351. doi: 10.3760/cma.j.issn.1673-0860.2018.05.004.
3
[The clinical characteristics and treatment outcomes of 386 patients with hypopharyngeal cancer].386例下咽癌患者的临床特征及治疗结果
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Jun 7;51(6):433-9. doi: 10.3760/cma.j.issn.1673-0860.2016.06.007.
4
Prognostic Significance of Lymph Node Density in Patients with Hypopharyngeal Squamous Cell Carcinoma.下咽鳞状细胞癌患者淋巴结密度的预后意义
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1014-9. doi: 10.1245/s10434-015-4726-6. Epub 2015 Jul 16.
5
Management of contralateral N0 neck in pyriform sinus carcinoma.梨状窦癌对侧N0颈部的处理
Laryngoscope. 2006 Jul;116(7):1268-72. doi: 10.1097/01.mlg.0000225936.88411.71.
6
[Clinical characteristics of 97 hypopharyngeal carcinoma cases].97例下咽癌病例的临床特征
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Mar;29(6):542-6.
7
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.喉和下咽鳞状细胞癌的区域转移延迟、远处转移及第二原发性恶性肿瘤
Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028.
8
Lymph Node Ratio Predicts Recurrence and Survival for Patients with Resectable Stage 4 Hypopharyngeal Cancer.淋巴结比率可预测可切除的IV期下咽癌患者的复发及生存情况。
Ann Surg Oncol. 2017 Jun;24(6):1707-1713. doi: 10.1245/s10434-017-5770-1. Epub 2017 Jan 27.
9
Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx.喉外侵犯范围的定量分析及其预后意义:170例喉癌和下咽癌的前瞻性研究
Head Neck. 1998 Jan;20(1):16-21. doi: 10.1002/(sici)1097-0347(199801)20:1<16::aid-hed3>3.0.co;2-6.
10
[Outcome of neck dissection for 154 cN0/cN1 patients with squamous cell carcinoma of hypopharynx and prognostic analysis].[154例下咽鳞状细胞癌cN0/cN1患者颈清扫术的结果及预后分析]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Apr 7;54(4):272-279. doi: 10.3760/cma.j.issn.1673-0860.2019.04.007.

引用本文的文献

1
Prognostic Factors and Long-Term Outcome Prediction in Patients with Hypopharyngeal Carcinoma Treated with (Chemo)radiotherapy: Development of a Prognostic Model.下咽癌患者接受(化疗)放疗后的预后因素及长期结局预测:一种预后模型的建立
Biomedicines. 2025 Feb 9;13(2):417. doi: 10.3390/biomedicines13020417.
2
Significance of P53-Binding Protein 1 as a Novel Molecular Histological Marker for Hypopharyngeal Squamous Neoplasms.P53结合蛋白1作为下咽鳞状肿瘤新型分子组织学标志物的意义
Cancers (Basel). 2024 Aug 28;16(17):2987. doi: 10.3390/cancers16172987.
3
Comprehensive prognostic modeling of locoregional recurrence after radiotherapy for patients with locoregionally advanced hypopharyngeal squamous cell carcinoma.

本文引用的文献

1
Management of advanced hypopharyngeal and laryngeal cancer with and without cartilage invasion.伴或不伴软骨侵犯的晚期下咽癌和喉癌的管理
Auris Nasus Larynx. 2017 Jun;44(3):333-339. doi: 10.1016/j.anl.2016.08.002. Epub 2016 Aug 25.
2
Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.原发灶手术与放化疗治疗局部晚期下咽鳞癌的疗效比较
JAMA Otolaryngol Head Neck Surg. 2015 Jul;141(7):636-40. doi: 10.1001/jamaoto.2015.0659.
3
Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.
局部晚期下咽鳞状细胞癌患者放疗后局部区域复发的综合预后模型
Front Oncol. 2023 Mar 21;13:1129918. doi: 10.3389/fonc.2023.1129918. eCollection 2023.
4
Single-cell discovery of the scene and potential immunotherapeutic target in hypopharyngeal tumor environment.单细胞发现下咽肿瘤微环境中的场景和潜在免疫治疗靶点。
Cancer Gene Ther. 2023 Mar;30(3):462-471. doi: 10.1038/s41417-022-00567-x. Epub 2022 Dec 2.
5
Computed tomography-based radiomics signature as a pretreatment predictor of progression-free survival in locally advanced hypopharyngeal carcinoma with a different response to induction chemotherapy.基于计算机断层扫描的放射组学特征可作为诱导化疗后局部晚期下咽癌无进展生存期的预测因子。
Eur Arch Otorhinolaryngol. 2022 Jul;279(7):3551-3562. doi: 10.1007/s00405-022-07306-w. Epub 2022 Feb 25.
6
A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Hypopharyngeal Squamous Cell Carcinomas: A Population-Based Study.基于网络的老年下咽鳞癌患者癌症特异性生存预测模型:一项基于人群的研究。
Front Public Health. 2022 Jan 13;9:815631. doi: 10.3389/fpubh.2021.815631. eCollection 2021.
7
Cancer of Pharyngoesophageal Junction: A Different Subtype From Hypopharyngeal and Cervical Esophageal Cancer?下咽食管交界处癌:一种与下咽癌和颈段食管癌不同的亚型?
Front Oncol. 2021 Nov 2;11:710245. doi: 10.3389/fonc.2021.710245. eCollection 2021.
8
[Postoperative prognostic risk factors and treatment strategies for patients with T3-T4 hypopharyngeal squamous cell carcinoma].[T3-T4期下咽鳞状细胞癌患者术后预后危险因素及治疗策略]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 May;35(5):400-404;409. doi: 10.13201/j.issn.2096-7993.2021.05.004.
9
Risk factors of lymphovascular invasion in hypopharyngeal squamous cell carcinoma and its influence on prognosis.下咽鳞癌脉管侵犯的危险因素及其对预后的影响。
Eur Arch Otorhinolaryngol. 2022 Mar;279(3):1473-1479. doi: 10.1007/s00405-021-06906-2. Epub 2021 Jun 2.
10
Time between Diagnosis and Treatment of Hypopharynx and Larynx Cancer: Are Longer Delays Associated with Higher Discrepancy between Clinical and Pathological Staging?下咽癌和喉癌诊断与治疗之间的时间间隔:较长的延迟是否与临床分期和病理分期之间的较高差异相关?
Int Arch Otorhinolaryngol. 2021 Jan;25(1):e108-e114. doi: 10.1055/s-0040-1708898. Epub 2020 May 4.
头颈部癌症临床实践指南(2013 年第 2 版). NCCN 指南的更新要点.
J Natl Compr Canc Netw. 2013 Aug;11(8):917-23. doi: 10.6004/jnccn.2013.0113.
4
Partial laryngopharyngectomy in the treatment of squamous cell carcinoma of hypopharynx: analysis of the oncologic results and laryngeal preservation rate.下咽部分喉咽切除术治疗下咽鳞状细胞癌:肿瘤学结果及喉保留率分析
Acta Otolaryngol. 2012 Dec;132(12):1342-6. doi: 10.3109/00016489.2012.700122. Epub 2012 Oct 10.
5
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.美国癌症联合委员会:第 7 版 AJCC 癌症分期手册与 TNM 的未来。
Ann Surg Oncol. 2010 Jun;17(6):1471-4. doi: 10.1245/s10434-010-0985-4.
6
Clinical and pathologic predictors of survival in patients with squamous cell carcinoma of the hypopharynx after surgical treatment.下咽鳞状细胞癌患者手术治疗后生存的临床及病理预测因素
Ann Otol Rhinol Laryngol. 2008 Mar;117(3):201-6. doi: 10.1177/000348940811700307.
7
Hypoxia in cancer: significance and impact on clinical outcome.癌症中的缺氧:意义及其对临床结局的影响。
Cancer Metastasis Rev. 2007 Jun;26(2):225-39. doi: 10.1007/s10555-007-9055-1.
8
A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction.下咽食管交界处鳞状细胞癌外科治疗的重新评估
J Surg Oncol. 2006 May 1;93(6):468-76. doi: 10.1002/jso.20472.
9
Patterns of spread in recurrent head and neck squamous cell carcinoma.复发性头颈部鳞状细胞癌的扩散模式
Otolaryngol Head Neck Surg. 2001 Oct;125(4):393-6. doi: 10.1067/mhn.2001.117715.
10
Current status of surgery for carcinoma of the hypopharynx and cervical esophagus.下咽及颈段食管癌的外科治疗现状
Dis Esophagus. 2001;14(2):95-7. doi: 10.1046/j.1442-2050.2001.00163.x.